Results 41 to 50 of about 11,098,658 (171)
Non-arteritic anterior ischemic optic neuropathy (NAION) is the most common cause of acute optic neuropathy in patients over the age of 50, and yet its exact mechanism of action remains unclear (1).
Evan Jameyfield; Karthik Kumar; Joseph Geraghty; Peter MacIntosh; Virna Shah
core
Background An effective treatment for acute non-arteritic ischemic optic neuropathy (NA-AION) has not been known or proven yet. Previous studies have suggested a neuroprotective effect of allogeneic bone marrow-derived mesenchymal stem cells.
Jose C. Pastor +7 more
doaj +1 more source
ABSTRACT Artificial intelligence (AI) has advanced rapidly in glaucoma, but many models remain optimized for case‐control detection rather than the clinically harder task of distinguishing glaucoma from its mimickers. This narrative review primarily examined literature published from January 2018 to March 2026 on glaucoma AI, difficult comparator ...
Cansu Yüksel Elgin
wiley +1 more source
Optic Nerve Thickness Assessed by Ocular Ultrasonography in Obstructive Sleep Apnea
Objectives Obstructive sleep apnea (OSA) has been associated with various ocular complications, yet ultrasonographic evaluation of optic nerve thickness and its relationship with nocturnal hypoxemia remains poorly understood. This study aimed to evaluate optic nerve thickness and globe dimensions using ocular ultrasonography in patients with different ...
Buğra Kerget +4 more
wiley +1 more source
A Rare Case of Bilateral Arteritic Posterior Ischemic Optic Neuropathy
Arteritic anterior ischemic optic neuropathy (AAION) is the most common, but by no means the only cause of severe acute vision loss in giant cell arteritis (GCA).
William Trask; Michael Mak; Rhiannon Brett
core
Anti‐obesity medications and incident ocular outcomes: A systematic review and network meta‐analysis
In this systematic review and network meta‑analysis of 140 studies, anti‑obesity medications showed heterogeneous ocular safety profiles. Semaglutide was associated with higher NAION risk (observational data), whereas dual/multi‑agonists and glucagon‐like peptide‐1 receptor agonists demonstrated favourable glaucoma and overall ocular outcomes ...
Linge Jian +5 more
wiley +1 more source
A 60-year-old white woman presented to the emergency department with painless decrease of visual acuity in the left eye (LE). The diagnosis of a non-arteritic anterior ischemic optic neuropathy in the LE was established based on the clinical picture and ...
Lech Sedlak +2 more
doaj +1 more source
Across 11 observational studies comprising 6 471 577 patients, the pooled incidence of ischaemic optic neuropathy after cardiac surgery was approximately 1.5 cases per 10 000 procedures. Coronary artery disease, peripheral vascular disease and anaemia were associated with increased odds of ION, although these findings should be interpreted in the ...
Daud Mutahar +11 more
wiley +1 more source
Submacular and Intraretinal Fluid Associated with Arteritic Anterior Ischemic Optic Neuropathy
Introduction: Anterior ischemic optic neuropathy (AION) is an ischemic disorder of the optic nerve and a common cause of acute, painless, permanent vision loss.
Danielle Solish, Jonathan Micieli
doaj +1 more source
Abstract Purpose To investigate the association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) use and nonarteritic anterior ischaemic optic neuropathy (NAION) in type 2 diabetes, examining treatment recency and cumulative duration. Methods This nationwide registry‐based nested case–control study utilizedz Danish health registries (1996 ...
Siar Niazi +9 more
wiley +1 more source

